Elucidating the Potential Compounds Targeting OPNL1W Through Virtual Screening for the Treatment of Color Blindness. Molecular Medicine Communications, [S. l.], v. 4, n. 01, p. 31–42, 2024. DOI: 10.55627/mmc.004.001.0462. Disponível em: http://rootspress.org/journals/index.php/MMC/article/view/462. Acesso em: 15 sep. 2024.